RADIOIMMUNOTHERAPY CASES REGISTRY: RECURRENT OR REFRACTORY NON-HODGKIN LYMPHOMA TREATED WITH 90Y-IBRITUMOMAB TIUXETAN

被引：0
|
作者：
Gomez-Codina, J. [1 ]
Giraldo, P. [2 ]
机构：
[1] Univ Hosp La Fe, Valencia, Spain
[2] Hosp U Miguel Servet, Dept Haematol, Zaragoza, Spain
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：232 / 232
页数：1
相关论文
共 50 条
  • [41] Experience on Therapy with 90Y Ibritumomab Tiuxetan in Relapsed/Refractory Non-Hodgkin Lymphoma. Analysis of Outcomes
    Baringo, T.
    Giraldo, P.
    Lievano, P.
    Navarro, P.
    Arroyo, E.
    Ananos, M.
    de la Cueva, L.
    Abos, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S352 - S352
  • [42] A phase 2 study of 90Y-Ibritumomab tiuxetan (90Y-Zevalin®) in relapsed/refractory non-Hodgkin's lymphoma:: Preliminary report of the Argentinean cooperative group.
    Cacchione, Roberto E.
    Milone, Jorge
    Bordone, Javier
    Dupont, Juan
    Milone, Gustavo
    Riveros, Dardo
    Negri, Pedro
    Ardaiz, Maria
    Riera, Leandro
    Foncuberta, Maria Cecilia
    Bezares, Fernando
    BLOOD, 2006, 108 (11) : 254B - 254B
  • [43] Radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin) in treatment of CD 20 positive mature B-cell non-Hodgkin's lymphoma: Initial experience.
    Khan, H. A. K.
    Shemmari, S. A. S.
    Sajnani, K. S.
    Mohannadi, S. A. M.
    Huda, F. A. H.
    Usmani, S. U.
    Abdulla, M. M. A.
    Mahmoud, S. A. D.
    Javaid, A. J.
    Sahi, Z. M. S.
    Wael, W. A.
    Ghaniem, I. G.
    Parekh, H. G. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S168 - S168
  • [44] Radioimmun therapy with (90)Y-Ibritumomab tiuxetan in patients with non-hodgkin's lymphoma
    Kaya, H.
    Ayyildiz, O.
    Altunci, G. Kaya
    Bellur, B. Kizilkan
    Isikdogan, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S420 - S420
  • [45] Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma
    McKinney, Matthew S.
    Beaven, Anne W.
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2014, 4 : 45 - 59
  • [46] Ibritumomab tiuxetan for non-Hodgkin's lymphoma
    Johnston, Patrick B.
    Bondly, Cara
    Micallef, Ivana N. M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 861 - 869
  • [47] 90Y-ibritumomab tiuxetan (90Y-Zevalin) radioimmunotherapy as a consolidation strategy in mantle cell lymphoma (MCL) patients
    Jurczak, W.
    Giza, A.
    Hubalewska-Dydejczyk, A.
    Sowa-Staszczak, A.
    Glowa, B.
    Szostek, M.
    Krochmalczyk, D.
    Wegrzyn, J.
    Knopinska-Posluszny, W.
    Zdziarska, B.
    Kyrcz-Krzemien, S.
    Poplawska, L.
    Walewski, J.
    Wrobel, T.
    Skotnicki, A. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S168 - S168
  • [48] Timing between rituximab and 90Y-ibritumomab tiuxetan in pts with Non-Hodgkin's lymphoma does not affect clinical outcomes.
    Friedman, Isaiah E.
    Andreadis, Charalambos
    Diangi, Yumi Taylor
    Nasta, Sunita D.
    Luger, Selina M.
    Stadtmauer, Edward A.
    Schuster, Stephen J.
    BLOOD, 2006, 108 (11) : 267B - 267B
  • [49] Assessment of Metabolic Response to Radioimmunotherapy (RIT) with Yttrium-90 (Y-90) Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-cell non-Hodgkin Lymphoma
    Storto, G.
    Nardelli, A.
    Pellegrino, T.
    Perna, F.
    De Falco, T.
    Erra, P.
    Ortosecco, G.
    Castaldi, E.
    Speranza, A.
    Klain, M.
    De Renzo, A.
    di Nuzzo, C.
    Pace, L.
    Rotoli, B.
    Salvatore, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S148 - S148
  • [50] RADIOIMMUNOTHERAPY OF (90Y)-IBRITUMOMAB TIUXETAN FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA AND FOLLICULAR LYMPHOMA
    Yoshida, Isao
    Kogure, Yuuki
    Kajihara, Makoto
    ANNALS OF ONCOLOGY, 2014, 25
12345